Cargando…

Therapy Side Effects in Systemic Lupus Erythematosus

Glucosteroids (GS) are widely used drugs for various inflammatory pathologies (Nephrotic syndrome, Proliferative glomerulonephritis, Extramembrane glomerulonephritis, Nephropathy of the Nodous Poliarterita (PAN), Nephropathy from purple Henoch-Schonlein, lupus nephropathy (LN), Acute adrenal insuffi...

Descripción completa

Detalles Bibliográficos
Autores principales: POPA, R., LAUTARU, L.A., LUCRETIU, R., RUIU, D.C., CARAGEA, D., OLTEANU, M., MIHAILOVICI, A.R., ENE, C., PADUREANU, V., PADUREANU, R., CIRLIG, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311221/
https://www.ncbi.nlm.nih.gov/pubmed/30647955
http://dx.doi.org/10.12865/CHSJ.44.03.18
_version_ 1783383571665256448
author POPA, R.
LAUTARU, L.A.
LUCRETIU, R.
RUIU, D.C.
CARAGEA, D.
OLTEANU, M.
MIHAILOVICI, A.R.
ENE, C.
PADUREANU, V.
PADUREANU, R.
CIRLIG, V.
author_facet POPA, R.
LAUTARU, L.A.
LUCRETIU, R.
RUIU, D.C.
CARAGEA, D.
OLTEANU, M.
MIHAILOVICI, A.R.
ENE, C.
PADUREANU, V.
PADUREANU, R.
CIRLIG, V.
author_sort POPA, R.
collection PubMed
description Glucosteroids (GS) are widely used drugs for various inflammatory pathologies (Nephrotic syndrome, Proliferative glomerulonephritis, Extramembrane glomerulonephritis, Nephropathy of the Nodous Poliarterita (PAN), Nephropathy from purple Henoch-Schonlein, lupus nephropathy (LN), Acute adrenal insufficiency Waterhouse-Friederichsen, Chronic adrenal insufficiency Addison, Systemic Lupus Erythematosus (SLE), Polymyositis and dermatomyositis, Chronic granulomatosis, Crohn's disease, Hemorrhagic rectocolitis, Hemolytic anemias, Acute leukemias and chronic lymphocytic leukemia, Hodgkin's lymphoma). Although they are prescribed for their anti-inflammatory and immunosuppressive properties, they also have many side effects, hyperglycemia being one of the most common and representative, which is why these drugs need careful monitoring when administered over the long term. This paper presents the case of a 39 year old patient diagnosed with systemic lupus erythematosus (SLE) with class IV lupus nephropathy (LN) who developed numerous complications due to the pathogenic side effects: diabetes, amenorrhea, recurrent infections, and depression.
format Online
Article
Text
id pubmed-6311221
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medical University Publishing House Craiova
record_format MEDLINE/PubMed
spelling pubmed-63112212019-01-15 Therapy Side Effects in Systemic Lupus Erythematosus POPA, R. LAUTARU, L.A. LUCRETIU, R. RUIU, D.C. CARAGEA, D. OLTEANU, M. MIHAILOVICI, A.R. ENE, C. PADUREANU, V. PADUREANU, R. CIRLIG, V. Curr Health Sci J Case Report Glucosteroids (GS) are widely used drugs for various inflammatory pathologies (Nephrotic syndrome, Proliferative glomerulonephritis, Extramembrane glomerulonephritis, Nephropathy of the Nodous Poliarterita (PAN), Nephropathy from purple Henoch-Schonlein, lupus nephropathy (LN), Acute adrenal insufficiency Waterhouse-Friederichsen, Chronic adrenal insufficiency Addison, Systemic Lupus Erythematosus (SLE), Polymyositis and dermatomyositis, Chronic granulomatosis, Crohn's disease, Hemorrhagic rectocolitis, Hemolytic anemias, Acute leukemias and chronic lymphocytic leukemia, Hodgkin's lymphoma). Although they are prescribed for their anti-inflammatory and immunosuppressive properties, they also have many side effects, hyperglycemia being one of the most common and representative, which is why these drugs need careful monitoring when administered over the long term. This paper presents the case of a 39 year old patient diagnosed with systemic lupus erythematosus (SLE) with class IV lupus nephropathy (LN) who developed numerous complications due to the pathogenic side effects: diabetes, amenorrhea, recurrent infections, and depression. Medical University Publishing House Craiova 2018 2018-07-15 /pmc/articles/PMC6311221/ /pubmed/30647955 http://dx.doi.org/10.12865/CHSJ.44.03.18 Text en Copyright © 2018, Medical University Publishing House Craiova http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Case Report
POPA, R.
LAUTARU, L.A.
LUCRETIU, R.
RUIU, D.C.
CARAGEA, D.
OLTEANU, M.
MIHAILOVICI, A.R.
ENE, C.
PADUREANU, V.
PADUREANU, R.
CIRLIG, V.
Therapy Side Effects in Systemic Lupus Erythematosus
title Therapy Side Effects in Systemic Lupus Erythematosus
title_full Therapy Side Effects in Systemic Lupus Erythematosus
title_fullStr Therapy Side Effects in Systemic Lupus Erythematosus
title_full_unstemmed Therapy Side Effects in Systemic Lupus Erythematosus
title_short Therapy Side Effects in Systemic Lupus Erythematosus
title_sort therapy side effects in systemic lupus erythematosus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311221/
https://www.ncbi.nlm.nih.gov/pubmed/30647955
http://dx.doi.org/10.12865/CHSJ.44.03.18
work_keys_str_mv AT popar therapysideeffectsinsystemiclupuserythematosus
AT lautarula therapysideeffectsinsystemiclupuserythematosus
AT lucretiur therapysideeffectsinsystemiclupuserythematosus
AT ruiudc therapysideeffectsinsystemiclupuserythematosus
AT caragead therapysideeffectsinsystemiclupuserythematosus
AT olteanum therapysideeffectsinsystemiclupuserythematosus
AT mihailoviciar therapysideeffectsinsystemiclupuserythematosus
AT enec therapysideeffectsinsystemiclupuserythematosus
AT padureanuv therapysideeffectsinsystemiclupuserythematosus
AT padureanur therapysideeffectsinsystemiclupuserythematosus
AT cirligv therapysideeffectsinsystemiclupuserythematosus